Machine signal
Active cluster sell — 4 distinct insiders, $135.1K, window ends Aug 12, 2026.
Figures computed from official regulatory filings — .
Analysttarget 18.06 USD (+378%) · consensus 4.68/5 · 17 buy · 2 hold · 0 sell
Ownershipinsiders 15.5% · institutions 85.31% · short 11.0% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Wave Life Sciences, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) programs; and clinical programs for Duchenne muscular dystrophy and Huntington's disease, as well as various preclinical programs utilizing its RNA medicines platform. Wave Life Sciences, Inc. was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
16 buys145 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Wagner Heidi L | Sell | $42.1K | SEC |
| Tan Aik Na | Sell | $2.6K | SEC |
| TAKANASHI KEN | Sell | $23.2K | SEC |
| Rawcliffe Adrian | Sell | $67.2K | SEC |
| Wagner Heidi L | Exercise | $41.8K | SEC |
| Wagner Heidi L | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| RA CAPITAL MANAGEMENT, LLCtrack record | Buy | $30M | conv 51 | SEC |
| RA CAPITAL MANAGEMENT, LLCtrack record | Buy | $6.3M | conv 30 | SEC |
| RA CAPITAL MANAGEMENT, LLCtrack record | Buy | $16M | conv 35 | SEC |
| RA CAPITAL MANAGEMENT, LLCtrack record | Buy | $2.2M | conv 30 | SEC |
| TAKANASHI KEN | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| TAKANASHI KEN | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Francis Chris | Sell | $270.1K | SEC |
| Francis Chris | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Francis Chris | Exercise | $69.3K | SEC |
| Francis Chris | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Francis Chris | Sell | $229.4K | SEC |
| Francis Chris | Exercise | $72.6K | SEC |
| Moran Kyle | Sell | $48.3K | SEC |
| Vargeese Chandra | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Vargeese Chandra | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| BOLNO PAUL | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Francis Chris | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Moran Kyle | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Francis Chris | Sell | $25.3K | SEC |